4-Propargylthiomorpholine 1,1-Dioxide
CAS: 10442-03-2
Ref. 3D-FP171360
| 1g | Discontinued | ||
| 2g | Discontinued | ||
| 5g | Discontinued | ||
| 10g | Discontinued | ||
| 500mg | Discontinued |
Product Information
- 4-Prop-2-Yn-1-Ylthiomorpholine 1,1-Dioxide
4-Propargylthiomorpholine 1,1-dioxide is a molecule that has been injected and encapsulated. It is a paracrine molecule that can be used to treat infarcted areas of the heart in experimental animals. The experimental group was divided into two groups: one group with infarcted hearts and one group without infarcts. The experimental group with infarcted hearts was treated with 4-propargylthiomorpholine 1,1-dioxide while the control group received an injection of saline. The experimental group had significantly less infarction than the control group. The mechanism of action is not known but it may have reparative effects on cardiac tissue by activating mesenchymal stem cells to produce cardiomyocytes and endothelial cells, or it may have anti-inflammatory effects by inhibiting sulfonic acid release from macrophages in response to inflammation.
